Newsroom | NeoGenomics Laboratories

April 18, 2015

MultiOmyx™: A multiplexed immunofluorescent assay capable of profiling protein expression and phosphorylation, in combination with next-generation sequencing from a single FFPE tissue section

Literature

April 16, 2015

NeoGenomics Schedules its Q1 2015 Earnings Release for April 28, 2015

Press Release

March 21, 2015

ALK positivity rate is highly dependent on patient age

Literature

March 21, 2015

Genetic array analysis of follicular dendritic cell carcinoma

Literature

February 27, 2015

Synonymous polymorphisms in HOXB13 as a predictive factor for prostate cancer

Literature

February 24, 2015

NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014

Press Release

February 4, 2015

NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015

Press Release

January 22, 2015

NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014

Press Release

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients